首页> 外国专利> ANTIBODIES SPECIFIC FOR PROBNP (1-108) AND THEIR USE FOR THE DIAGNOSIS OF HERZINFARKT

ANTIBODIES SPECIFIC FOR PROBNP (1-108) AND THEIR USE FOR THE DIAGNOSIS OF HERZINFARKT

机译:概率(1-108)特异的抗体及其在赫兹汀诊断中的用途

摘要

Antibody (Ab) directed against proBNP(1-108) (A; BNP = brain natriuretic peptide), is new. Antibody (Ab) directed against proBNP(1-108) (A; BNP = brain natriuretic peptide) that: (a) recognizes specifically the sequence Arg-Ala-Pro-Arg76-Ser77-Pro (5) of (A) but does not significantly recognize the BNP peptides 1-76 and 77-108; and (b) recognizes specifically (A) circulating in human serum or plasma. Independent claims are also included for the following: (1) method for preparing Ab by immunization; (2) method for producing a hybridoma that secretes monoclonal Ab (MAb); (3) hybridoma produced by method (2); (4) MAb produced by the hybridoma of (3); (5) in vitro diagnosis of congestive heart failure in humans by using Ab or MAb to detect (A); (6) kit for detecting (A) containing Ab or MAb; (7) peptides of formulae (I)-(III); (8) peptides derived from (II) or (III) by replacing one or more of the amino acids 70, 71, 72, 79-85; (9) method for producing antibodies (Ab1) that recognize specifically sequences (II) and (III) (where X = hydrogen and Y = hydroxy) and/or (5) but not the 1-76 or 77-108 peptides, and can detect (A) in the circulation, by immunization with (I)-(III) or the derivatives of (8); (10) method for preparing hybridomas that produce Ab1; (11) Ab1 produced by method (9) or from the hybridomas of (10); (12) hybridomas of (10); (13) in vitro diagnosis of congestive heart failure in humans by using Ab1 to detect (A); (14) kit for detecting (A) containing Ab1 and/or at least one (II), (III) or the derivatives of (8). a1-X1-Arg-Ala-Pro-Arg-Ser-Pro-a2 (I); X-Tyr70-Thr-Leu-Arg-Ala-Pro-Arg76-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Z (II); X-Tyr70-Thr-Leu-Arg-Ala-Pro-Arg76-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Z (III) a1 = hydrogen, thiol, hydroxy, aminoxy, primary or secondary amino, aminocarbonyl, biotinyl or acetyl; X1 = 0-3 peptide amino acids (paa), optionally derived from proBNP; X2 = 0-7 paa, optionally derived from proBNP; a2 = hydroxy, amino or alkoxy; X = hydrogen, acetyl, 1-3 aa that are not part of proBNP; Z = hydroxy or 1-3 aa that are not part of proBNP.
机译:针对proBNP(1-108)的抗体(Ab)(A; BNP =脑利钠肽)是新的。针对proBNP(1-108)的抗体(Ab)(A; BNP =脑利钠肽):(a)特异性识别(A)的Arg-Ala-Pro-Arg76-Ser77-Pro(5)序列,但不能明显识别BNP肽1-76和77-108; (b)专门识别(A)在人血清或血浆中循环。还包括以下方面的独立权利要求:(1)通过免疫制备抗体的方法; (2)产生分泌单克隆抗体(MAb)的杂交瘤的方法。 (3)通过方法(2)产生的杂交瘤; (4)(3)的杂交瘤产生的MAb; (5)利用Ab或MAb检测(A)体外诊断人的充血性心力衰竭; (6)用于检测(A)含有Ab或MAb的试剂盒; (7)式(I)-(III)的肽; (8)通过替换氨基酸70、71、72、79-85中的一个或多个而衍生自(II)或(III)的肽; (9)产生特异性识别序列(II)和(III)(其中X =氢且Y =羟基)和/或(5)但不识别1-76或77-108肽的抗体(Ab1)的方法,和通过用(I)-(III)或(8)的衍生物进行免疫可以检测循环中的(A); (10)制备产生Ab1的杂交瘤的方法; (11)通过方法(9)或从(10)的杂交瘤产生的Ab1; (12)(10)的杂交瘤; (13)利用Ab1检测(A)体外诊断人的充血性心力衰竭; (14)用于检测(A)的试剂盒,其包含Ab1和/或至少一种(II),(III)或(8)的衍生物。 a1-X1-Arg-Ala-Pro-Arg-Ser-Pro-a2(I); X-Tyr70-Thr-Leu-Arg-Ala-Pro-Arg76-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Z(II); X-Tyr70-Thr-Leu-Arg-Ala-Pro-Arg76-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Z(III)a1 =氢,硫醇,羟基,氨氧基,伯或仲氨基,氨基羰基,生物素基或乙酰基; X1 = 0-3个肽氨基酸(paa),可选衍生自proBNP; X2 = 0-7 paa,可选地源自proBNP; a2 =羟基,氨基或烷氧基; X =不属于proBNP的氢,乙酰基,1-3个氨基酸; Z =不属于proBNP的羟基或1-3个氨基酸。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号